肝移植中的正常化内在死亡风险:欧洲肝移植注册表的研究
1ELTR Coordinating Centre, Paul Brousse Hospital, Villejuif, France. rene.adam@pbr.ap-hop-paris.fr
Lancet (London, England)
|September 1, 2000
概括
一个新的模型通过将内在风险与已知的因素相结合来估计肝移植死亡风险. 这使得中心能够评估绩效并改善患者的治疗结果.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植手术 移植手术
- 生物统计学 生物统计学
背景情况:
- 现有的模型没有准确估计肝移植死亡风险.
- 缺乏评估移植中心绩效的标准方法.
- 需要了解独立于已知的因素的内在死亡风险.
研究的目的:
- 开发一个模型,估计肝移植时的内在死亡风险.
- 识别和量化关键的死亡风险因素及其比率.
- 为了能够客观地评估移植中心的表现.
主要方法:
- 利用了欧洲肝脏移植登记处的数据 (1988-1997年,欧洲肝脏移植登记处的22,089名患者,102个中心,18个国家).
- 进行单变量和多变量分析以确定风险因素和估计风险比率.
- 通过比较风险因素和没有风险因素的患者的预测死亡率和实际死亡率来验证模型.
主要成果:
- 总体5年生存率为66%;65%的死亡发生在6个月内.
- 确定了再移植,癌症,急性肝衰竭和低中心体积作为关键风险因素.
- 模型调整后的死亡率与没有风险因素的成人和儿童的观察率非常相匹配.
- 大批量中心的死亡风险降低明显更大 (48%对23%).
结论:
- 一个规范化的内在死亡风险模型,结合风险比率,改善死亡率预测.
- 这种模型允许中心通过减轻选择偏差来客观地评估绩效.
- 能够在肝移植中更好地选择患者和分配资源.
更多相关视频
05:25Preservation of Porcine Donation after Circulatory Death (DCD) Liver by Perfusion and Orthotopic Liver Transplantation
Published on: June 14, 2024
11:25Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
Published on: March 8, 2024
相关概念视频
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...